BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 27157369)

  • 1. Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis.
    Pierorazio PM; Johnson MH; Patel HD; Sozio SM; Sharma R; Iyoha E; Bass EB; Allaf ME
    J Urol; 2016 Oct; 196(4):989-99. PubMed ID: 27157369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.
    Patel HD; Pierorazio PM; Johnson MH; Sharma R; Iyoha E; Allaf ME; Bass EB; Sozio SM
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1057-1069. PubMed ID: 28483780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours.
    Katsanos K; Mailli L; Krokidis M; McGrath A; Sabharwal T; Adam A
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):427-37. PubMed ID: 24482030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Surveillance in Small Renal Masses in the Elderly: A Literature Review.
    Cheung DC; Finelli A
    Eur Urol Focus; 2017 Oct; 3(4-5):340-351. PubMed ID: 29175368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cT1a Renal Masses Less Than 2 versus 2 cm or Greater Managed by Robotic Partial Nephrectomy: A Propensity Score Matched Comparison of Perioperative Outcomes.
    Bertolo R; Garisto J; Dagenais J; Sagalovich D; Agudelo J; Stein R; Fareed K; Gao T; Fergany A; Kaouk J
    J Urol; 2019 Jan; 201(1):56-61. PubMed ID: 30100402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma.
    Kang M; Gong IH; Park HJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Choi HY; Il Seo S
    J Endourol; 2017 Dec; 31(12):1231-1236. PubMed ID: 29048228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal therapy versus robot-assisted partial nephrectomy in the management of clinical T1 renal masses: A systematic review and meta-analysis.
    Yoon YE; Lee HH; Kim KH; Park SY; Moon HS; Lee SR; Hong YK; Park DS; Kim DK
    Medicine (Baltimore); 2018 Nov; 97(45):e13102. PubMed ID: 30407321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for T1a Renal Cancer Substratified by Size: "Less is More".
    Moskowitz D; Chang J; Ziogas A; Anton-Culver H; Clayman RV
    J Urol; 2016 Oct; 196(4):1000-7. PubMed ID: 27113965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
    Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
    Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer.
    MacLennan S; Imamura M; Lapitan MC; Omar MI; Lam TB; Hilvano-Cabungcal AM; Royle P; Stewart F; MacLennan G; MacLennan SJ; Dahm P; Canfield SE; McClinton S; Griffiths TR; Ljungberg B; N'Dow J; ;
    Eur Urol; 2012 Dec; 62(6):1097-117. PubMed ID: 22841673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Extensive Parenchymal Resection During Robotic Partial Nephrectomy Justified? A Match-Paired Comparison of Two Extirpative Surgical Modalities for Treatment of a Complex Renal Neoplasm.
    Andrade HS; Zargar H; Akca O; Caputo PA; Ramirez D; Kara O; Stein RJ; Chueh SC; Kaouk JH
    J Endourol; 2016 Apr; 30(4):379-83. PubMed ID: 26486995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological and Functional Outcomes of Laparoscopic Radiofrequency Ablation and Partial Nephrectomy for T1a Renal Masses: A Retrospective Single-center 60 Month Follow-up Cohort Study.
    Park JM; Yang SW; Shin JH; Na YG; Song KH; Lim JS
    Urol J; 2019 Feb; 16(1):44-49. PubMed ID: 30120758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcomes of tumor recurrence after focal ablation renal therapy.
    Breda A; Anterasian C; Belldegrun A
    J Endourol; 2010 May; 24(5):749-52. PubMed ID: 20443716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.